N-(2,3-dihydroxypropyl)valine: structure in first source
ID Source | ID |
---|---|
PubMed CID | 23088918 |
MeSH ID | M0373336 |
Synonym |
---|
AKOS017532138 |
n-(2,3-dihydroxypropyl)valine |
2-[(2,3-dihydroxypropyl)amino]-3-methylbutanoic acid |
EN300-6526731 |
1210318-11-8 |
Excerpt | Reference | Relevance |
---|---|---|
"In order to quantify the relative bioavailability of glycidol from glycidyl fatty acid esters in vivo, glycidyl palmitoyl ester and glycidol were orally applied to rats in equimolar doses." | ( Relative oral bioavailability of glycidol from glycidyl fatty acid esters in rats. Abraham, K; Apel, E; Appel, KE; Bakhiya, N; Berger-Preiss, E; Creutzenberg, O; Hansen, T; Lampen, A; Schuchardt, S; Vogt, C, 2013) | 0.39 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 6 (75.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.13) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |